CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $103 | $99 | $95 | $98 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Cost of Goods Sold | $89 | $85 | $80 | $85 |
| Gross Profit | $14 | $14 | $14 | $13 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $17 | $11 | $11 | $11 |
| Operating Expenses | $17 | $11 | $11 | $11 |
| Operating Income | -$3 | $2 | $3 | $2 |
| % Margin | -3.1% | 2.4% | 3.6% | 2.4% |
| Other Income/Exp. Net | -$0 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$3 | $2 | $3 | $2 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | -$4 | $1 | $2 | $2 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS | -3.13 | 0.81 | 1.41 | 1.31 |
| % Growth | -486.4% | -42.6% | 7.6% | – |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$2 | $4 | $5 | $4 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |